Icopezil

CAS No. 145508-78-7

Icopezil( —— )

Catalog No. M36181 CAS No. 145508-78-7

Icopezil is a small molecule acetylcholinesterase in (AChE) inhibitor for the treatment of neurological disorders and can be used in the study of Alzheimer's disease.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 257 In Stock
10MG 380 In Stock
25MG 635 In Stock
50MG 883 In Stock
100MG 1200 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Icopezil
  • Note
    Research use only, not for human use.
  • Brief Description
    Icopezil is a small molecule acetylcholinesterase in (AChE) inhibitor for the treatment of neurological disorders and can be used in the study of Alzheimer's disease.
  • Description
    Icopezil is a small molecule acetylcholinesterase in (AChE) inhibitor for the treatment of neurological disorders and can be used in the study of Alzheimer's disease.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    AChE
  • Recptor
    AChE
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    145508-78-7
  • Formula Weight
    375.46
  • Molecular Formula
    C23H25N3O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(CC1CCN(CC2=CC=CC=C2)CC1)C=3C4=C(C=C5C(=C4)CC(=O)N5)ON3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • (R)-Rivastigmine D6 ...

    (R)-Rivastigmine D6 tartrate is the deuterium labeled (R)-Rivastigmine, and is an inhibitor of cholinesterase.

  • TAK-802

    A potent acetylcholinesterase (AChE) inhibitor with IC50 of 1.3 nM.

  • Clozapine N-oxide di...

    Clozapine N-oxide dihydrochloride, a derivative of Clozapine and an agonist of human muscarinic design receptors (DREADDs), crosses the blood-brain barrier and activates DREADD receptors hM3Dq and hM4Di.